Next, CRC cells were treated with an EGFR inhibitor (AG1478, Calbiochem, La Jolla, CA, USA) to determine whether EGFR was required for the induction of EMT by the F. nucleatum and DSS co-treatment. The gene discussed is EGFR; the disease is colorectal carcinoma.